Pediatrix Medical Group Statistics

Total Valuation

BMV:MD has a market cap or net worth of MXN 23.11 billion. The enterprise value is 31.56 billion.

Market Cap	23.11B
Enterprise Value	31.56B

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	84.21M
Shares Outstanding	n/a
Shares Change (YoY)	+1.55%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	83.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	8.49
PS Ratio	0.57
PB Ratio	1.43
P/TBV Ratio	n/a
P/FCF Ratio	5.82
P/OCF Ratio	5.27
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.32, with an EV/FCF ratio of 7.95.

EV / Earnings	-18.75
EV / Sales	0.82
EV / EBITDA	6.32
EV / EBIT	8.13
EV / FCF	7.95

Financial Position

The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.83.

Current Ratio	1.81
Quick Ratio	1.74
Debt / Equity	0.83
Debt / EBITDA	2.57
Debt / FCF	3.37
Interest Coverage	5.04

Financial Efficiency

Return on equity (ROE) is -10.01% and return on invested capital (ROIC) is 8.04%.

Return on Equity (ROE)	-10.01%
Return on Assets (ROA)	5.95%
Return on Invested Capital (ROIC)	8.04%
Return on Capital Employed (ROCE)	11.50%
Revenue Per Employee	9.80M
Profits Per Employee	-408,614
Employee Count	4,120
Asset Turnover	0.95
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +97.26% in the last 52 weeks. The beta is 1.27, so BMV:MD's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	+97.26%
50-Day Moving Average	385.22
200-Day Moving Average	n/a
Relative Strength Index (RSI)	45.44
Average Volume (20 Days)	6,700

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.59

Income Statement

In the last 12 months, BMV:MD had revenue of MXN 40.39 billion and -1.68 billion in losses. Loss per share was -20.22.

Revenue	40.39B
Gross Profit	9.44B
Operating Income	4.05B
Pretax Income	-1.66B
Net Income	-1.68B
EBITDA	4.60B
EBIT	4.05B
Loss Per Share	-20.22

Full Income Statement

Balance Sheet

The company has 4.48 billion in cash and 13.39 billion in debt, giving a net cash position of -8.91 billion.

Cash & Cash Equivalents	4.48B
Total Debt	13.39B
Net Cash	-8.91B
Net Cash Per Share	n/a
Equity (Book Value)	16.13B
Book Value Per Share	191.76
Working Capital	4.51B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.38 billion and capital expenditures -408.98 million, giving a free cash flow of 3.97 billion.

Operating Cash Flow	4.38B
Capital Expenditures	-408.98M
Free Cash Flow	3.97B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 23.38%, with operating and profit margins of 10.02% and -4.17%.

Gross Margin	23.38%
Operating Margin	10.02%
Pretax Margin	-4.10%
Profit Margin	-4.17%
EBITDA Margin	11.40%
EBIT Margin	10.02%
FCF Margin	9.83%

Dividends & Yields

BMV:MD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.55%
Shareholder Yield	n/a
Earnings Yield	-7.29%
FCF Yield	17.19%

Stock Splits

The last stock split was on December 20, 2013. It was a forward split with a ratio of 2.

Last Split Date	Dec 20, 2013
Split Type	Forward
Split Ratio	2

Scores

BMV:MD has an Altman Z-Score of 1.77. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.77
Piotroski F-Score	n/a